WCP
CELG

Welch Capital Partners’s Celgene Corp CELG Stock Holding History

Welch Capital Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-37,030
Closed -$5.4M – 47
2017
Q3 		$5.4M Sell
37,030
-1,770
-5% -$241K 1.82% 28
2017
Q2 		$5.04M Buy
38,800
+70
+0.2% +$8.58K 1.67% 31
2017
Q1 		$4.82M Sell
38,730
-2,110
-5% -$253K 1.59% 29
2016
Q4 		$4.73M Buy
+40,840
New +$4.55M 1.6% 29

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Welch Capital Partners's CELG Position: Q4 2017 in Review

Welch Capital Partners sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 37,030 shares — an estimated $5.4M sold.

Welch Capital Partners first reported a position in CELG in Q4 2016 and held it in 4 quarters. The position peaked at $5.4M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Welch Capital Partners reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Welch Capital Partners sold 37,030 Celgene Corp shares in Q4 2017, an estimated $5.4M.
  • Welch Capital Partners first reported a position in Celgene Corp in Q4 2016 and held it in 4 quarters.
  • Welch Capital Partners's Celgene Corp position peaked at $5.4M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Welch Capital Partners's 13F filing for Q4 2017, filed 9 Feb 2018.